Beyond direct suppression of inflammatory mediators, HOCl may exert paracrine antagonism of tumor-promoting NF-κB signaling through myeloperoxidase (MPO) derived from innate immune cells [23]. This evidence concerns the gene NFKB1 and neoplasm.